We would like to thank you for the opportunity to address the issues raised by A.Watanabe
in his Letter to the Editor [
[1]
] and to clarify some methodological and analytical aspects of our study, while thanking
him for his interest in our paper.- Watanabe A.
Type of anticoagulation therapy in oldest old, frail people with atrial fibrillation.
Eur J Intern Med. 2021; https://doi.org/10.1016/j.ejim.2021.05.007
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of Internal MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Type of anticoagulation therapy in oldest old, frail people with atrial fibrillation.Eur J Intern Med. 2021; https://doi.org/10.1016/j.ejim.2021.05.007
- Long-term effectiveness and safety of anticoagulation therapy in oldest old, frail people with atrial fibrillation.Eur J Intern Med. 2021; 86: 91-97https://doi.org/10.1016/j.ejim.2021.01.020
Article info
Publication history
Published online: June 05, 2021
Accepted:
May 21,
2021
Received:
May 15,
2021
Identification
Copyright
© 2021 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
